Category: Regulations
-
Scrubbing Hydrogen Sulfide from Industrial Processes
If your factory creates hydrogen sulfide, you need to capture that gas as near the source as possible, for the safety of workers and the surrounding community.
-
Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.
-
Trial Set to Test Inhaled mRNA for Viral Infections
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.
-
Trial Okayed to Transplant Donated Islet Cells for Type 1 Diabetes
Health authorities in Sweden authorized the start of a clinical trial testing insulin-producing cells from donors engineered to prevent immune reactions in people with type 1 diabetes.
-
Keeping Conversations Positive with Precision Moderation
Sponsored content removed due to non-payment.
-
Infographic – Little Trust in Companies’ A.I. Use
A poll in the U.S. shows a large majority of Americans who heard of artificial intelligence have very little or no trust that companies will use the technology responsibly.
-
Genetic Tests of Breast Cancer Patients Shown Useful
Experiences from a rural hospital in North Carolina show hereditary genetic testing of all breast cancer patients is feasible and can result in changes in care for many patients.
-
FDA Funds Study of Real World Data for Biosimilars
A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs.
-
FDA Clears Genetic Cancer Risk Detection Test
The Food and Drug Administration authorized marketing of a genetic test for detecting hundreds of gene variants associated with a higher risk of developing certain cancers.
-
FDA Clears Biotech Seasonal Flu Treatment Trial
A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains.